Development of a new cyclosporine formulation based on poly(caprolactone) microspheres

Journal of Microencapsulation

Volumn 19, Issue 1, 2002, Pages 61-72

  Aberturas, M R ^a   Molpeceres, J ^a   Guzman M ^a   Garcia F ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Cyclosporine; Lyophilization; Microspheres; Poly(caprolactone); Stability

Indexed keywords

CRYOPROTECTIVE AGENT; CYCLOSPORIN A; MICROSPHERE; ORGANIC SOLVENT; POLYCAPROLACTONE; POLYMER; SORBITOL; SURFACTANT; TREHALOSE;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; CRYOPROTECTION; CRYSTALLIZATION; DISPERSION; DRUG ADMINISTRATION ROUTE; DRUG FORMULATION; DRUG STABILITY; DRUG STORAGE; EVAPORATION; FREEZE DRYING; PARTICLE SIZE; ROOM TEMPERATURE;

CALORIMETRY, DIFFERENTIAL SCANNING; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOSPORINE; DRUG COMPOUNDING; DRUG STABILITY; EXCIPIENTS; FREEZE DRYING; IMMUNOSUPPRESSIVE AGENTS; MICROSPHERES; MOLECULAR WEIGHT; PARTICLE SIZE; POLYESTERS;

EID: 0036148081     PISSN: 02652048     EISSN: None     Source Type: Journal    
DOI: 10.1080/02652040110055270     Document Type: Article

References (26)

1. Tissue concentration of nanoencapsulated radio-labelled cyclosporin following peroral delivery in mice or ophthalmic application in rabbits
2. Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery
3. Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A
4. A one-week subdermal delivery system for L-methadone based on biodegradable microcapsules
5. Optimized preparation of poly DL(lactic-glycolic) microspheres and nanoparticles for oral administration
6. Stability and freeze-drying of cyclosporine loaded poly(D,L lactide-glycolide) carriers
7. Biodegradable pseudolatexes: The chemical stability of poly(D,L-lactide) and poly(ε-caprolactone) nanoparticles in aqueous media
8. Nano- and micro-particles for the delivery of polypeptides and proteins
9. Is trehalose special for preserving dry biomaterials?
10. Freeze-drying of itraconazole-loaded nanosphere suspensions: A feasability study
11. Formulation and lyoprotection of poly (lactic acid-co-ethylene oxide) nanoparticles: Influence on physical stability and in vitro cell uptake
12. Production of BCG alginate-PLL microcapsules by emulsification/internal gelation
13. Cyclosporin clinical pharmacokinetics
14. Characterization and stability of various liposome-encapsulated enoxacin formulations
15. Cyclosporin: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders
16. The oral absorption of micro- and nanoparticulates: Neither exceptional nor unusual
17. poly(DL-lactide) nanocapsules containing diclofenac: I. Formulation and stability study
18. Formation and characterization of cyclosporine-loaded nanoparticles
19. Stability study of nanoparticles of poly(ε-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide)
20. Accelerated degradation of poly(ε-caprolactone) by organic amines
21. Biodegradable microcapsules: Acceleration of polymeric excipient hydrolytic rate by incorporation of a basic medicament
22. Biodegradable nanoparticles as a delivery system for cyclosporine: Preparation and characterization
23. Biodegradable microspheres in drug delivery
24. Poly(D,L-Lactide-co-glycolide) micro and nanospheres as a way to prolong blood/plasma levels of subcutaneously injected cyclosporin A
25. More about the degradation of LA/GA-derived matrices in aqueous media